Published in

American Chemical Society, Journal of Medicinal Chemistry, 17(65), p. 11703-11725, 2022

DOI: 10.1021/acs.jmedchem.2c00534

Links

Tools

Export citation

Search in Google Scholar

Discovery of (R)-N-Benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide [<b>(R)-AS-1</b>], a Novel Orally Bioavailable EAAT2 Modulator with Drug-like Properties and Potent Antiseizure Activity In Vivo

Journal article published in 2022 by Michał Abram ORCID, Marcin Jakubiec, Katelyn Reeb, Mary Hongying Cheng ORCID, Robin Gedschold, Anna Rapacz ORCID, Szczepan Mogilski, Katarzyna Socała ORCID, Dorota Nieoczym, Małgorzata Szafarz, Gniewomir Latacz, Bartłomiej Szulczyk, Justyna Kalinowska-Tłuścik ORCID, Kinga Gawel, Camila V. Esguerra and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
  • Must obtain written permission from Editor
  • Must not violate ACS ethical Guidelines
Upload
Orange circle
Postprint: archiving restricted
  • Must obtain written permission from Editor
  • Must not violate ACS ethical Guidelines
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO